+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Angiographic Catheters - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5301888
The global market for Angiographic Catheters was estimated at US$1.6 Billion in 2023 and is projected to reach US$2.5 Billion by 2030, growing at a CAGR of 6.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Angiographic Catheters Market - Key Trends and Drivers Summarized

What Are Angiographic Catheters, And Why Are They So Important?

Angiographic catheters are specialized medical devices designed to help doctors visualize the interior of blood vessels and the heart, enabling precise diagnosis and treatment of cardiovascular diseases. These catheters, typically thin, flexible tubes, are inserted into the blood vessels through a small incision and guided to the area of interest, where they inject contrast agents that allow for clear imaging during an angiography procedure. The images produced through this technique help healthcare providers assess the health of arteries, veins, and chambers of the heart, identifying blockages, aneurysms, and other vascular abnormalities.

The importance of angiographic catheters in modern medicine cannot be overstated, as they are integral to diagnosing conditions such as coronary artery disease (CAD), peripheral artery disease (PAD), and even strokes. By providing detailed imaging of blood flow and vessel structure, angiographic catheters empower clinicians to make informed decisions regarding the best treatment approach, whether it involves medical management, stenting, or surgery.

In What Ways Do Angiographic Catheters Enhance Cardiology And Other Fields?

Angiographic catheters are primarily used in cardiology, where they provide critical insights into coronary arteries, helping to diagnose and manage heart conditions like ischemic heart disease, myocardial infarction, and congenital defects. In many cases, the use of these catheters leads directly to life-saving interventions, such as angioplasty or the placement of stents to restore blood flow to the heart. However, their utility extends beyond the cardiovascular system. Angiographic catheters are also widely used in neurology for the diagnosis and treatment of cerebrovascular diseases, including stroke and brain aneurysms.

In interventional radiology, these catheters help visualize blood vessels in various parts of the body, including the kidneys, lungs, and limbs, to assess conditions such as deep vein thrombosis (DVT), pulmonary embolism, and peripheral vascular disease. The precision offered by angiographic catheters allows for minimally invasive procedures, reducing the need for open surgeries and shortening recovery times for patients. Moreover, advances in catheter design, including smaller diameters and improved flexibility, have broadened their applicability, enabling safe and effective access to even the most complex and delicate vascular structures in the body.

What Are the Different Types of Angiographic Catheters, And How Are They Used?

Angiographic catheters come in a variety of types, each designed for specific vascular regions and diagnostic needs. One of the most common types is the Judkins catheter, which is often used in coronary angiography to assess the coronary arteries. Its pre-shaped design allows for easy navigation through the aorta and precise positioning within the coronary arteries, providing clear imaging for cardiologists. Pigtail catheters, named for their spiral tip, are commonly used to inject contrast agents into larger chambers of the heart or the aorta, enabling imaging of these structures without damaging the vessel walls.

Similarly, Cobra and Renal catheters are specifically designed for vascular access in the kidneys and abdominal arteries, where their flexibility and curve aid in navigating challenging anatomical paths. Each catheter is carefully chosen based on the patient's anatomy and the area being examined, ensuring that the most accurate and detailed images are captured with minimal patient risk. Technological advancements have also led to the development of drug-coated catheters and those with sensors capable of measuring blood flow and pressure in real-time, allowing for simultaneous diagnostic and therapeutic procedures, which is particularly beneficial in emergency settings such as heart attacks or strokes.

What Factors Are Fueling the Growth of the Angiographic Catheter Market?

The growth in the angiographic catheters market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in imaging technologies, and a rising demand for minimally invasive procedures. Cardiovascular disease remains the leading cause of death globally, driving the need for early and accurate diagnosis through angiography. As populations age and the incidence of conditions like hypertension, diabetes, and high cholesterol rises, the demand for angiographic catheters continues to expand. Another significant growth driver is the advancement in catheter design and materials.

Modern angiographic catheters are more flexible, durable, and able to navigate complex vascular structures with greater ease, reducing procedural risks and improving patient outcomes. In addition, the integration of angiography with cutting-edge imaging technologies, such as high-definition fluoroscopy and 3D vascular mapping, has increased the demand for precision tools like angiographic catheters.

Hospitals and healthcare providers are also seeking out these devices to facilitate minimally invasive procedures, which offer shorter recovery times, fewer complications, and reduced hospital stays compared to traditional open surgeries. Moreover, the rise in catheter-based interventions, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR), further drives the need for sophisticated angiographic catheters that can operate within highly specialized fields. Lastly, growing healthcare infrastructure in emerging markets, along with increasing awareness of cardiovascular health, is expanding access to angiography procedures, contributing to the continued expansion of the angiographic catheter market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Coronary Application segment, which is expected to reach US$911.8 Million by 2030 with a CAGR of a 7.5%. The Neurology Application segment is also set to grow at 6.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $418.4 Million in 2023, and China, forecasted to grow at an impressive 9.9% CAGR to reach $587.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Angiographic Catheters Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Angiographic Catheters Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Angiographic Catheters Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Angiographic Catheters Market such as Alvimedica Medical Devices Inc., Angiodynamics Inc, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc. (A Part of Becton, Dickinson and Company) and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Global Angiographic Catheters market report include:

  • Alvimedica Medical Devices Inc.
  • Angiodynamics Inc
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C.R. Bard, Inc. (A Part of Becton, Dickinson and Company)
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Medtronic PLC.
  • Merit Medical System Inc
  • Terumo Medical Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Angiographic Catheters - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Cardiovascular Diseases Throws the Spotlight on Angiographic Catheter Demand
  • Increasing Number of Minimally Invasive Procedures Propels Growth in the Angiographic Catheters Market
  • Advancements in Imaging and Catheter Materials Strengthen the Business Case for Advanced Angiographic Catheters
  • Surge in Aging Population Accelerates Demand for Diagnostic and Therapeutic Angiographic Procedures
  • Expanding Use of Angiographic Catheters in Neurological and Peripheral Vascular Procedures Drives Market Growth
  • Increasing Adoption of Interventional Radiology Expands the Addressable Market for Angiographic Catheters
  • Focus on Reducing Procedural Complications Spurs Demand for High-Precision Catheters with Enhanced Navigability
  • Growth in Outpatient and Ambulatory Surgical Centers Generates Opportunities for Angiographic Catheter Use
  • Innovations in Catheter Coating and Anti-Thrombogenic Technologies Propel Demand for Safer and More Efficient Devices
  • Growing Focus on Early Disease Detection and Preventive Healthcare Drives Adoption of Diagnostic Angiographic Catheters
  • Increasing Integration of Robotics and AI in Vascular Procedures Strengthens the Business Case for Next-Generation Angiographic Catheters
  • Rising Use of Angiographic Catheters in Oncology for Tumor Embolization and Targeted Therapies Propels Market Growth
  • Growing Adoption of Hybrid Operating Rooms Accelerates the Demand for Advanced Imaging-Compatible Angiographic Catheters
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Angiographic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Angiographic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Angiographic Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Coronary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Endovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Endovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Endovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Angiographic Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: USA Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: USA 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: USA Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: USA 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: Canada 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: Canada 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 41: Japan Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: Japan 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: Japan 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 47: China Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: China Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: China 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: China Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: China 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 53: Europe Recent Past, Current & Future Analysis for Angiographic Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Angiographic Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Angiographic Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: Europe 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 61: Europe 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 62: France Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: France Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 64: France 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 65: France Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: France Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 67: France 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 68: Germany Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 70: Germany 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 71: Germany Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 73: Germany 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
  • Table 74: Italy Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 76: Italy 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 77: Italy Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 79: Italy 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 80: UK Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: UK Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 82: UK 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 83: UK Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: UK Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 85: UK 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
  • Table 86: Spain Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Spain Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 88: Spain 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 89: Spain Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 90: Spain Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 91: Spain 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
  • Table 92: Russia Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Russia Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 94: Russia 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 95: Russia Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 96: Russia Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 97: Russia 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of Europe Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 100: Rest of Europe 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 101: Rest of Europe Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 102: Rest of Europe Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 103: Rest of Europe 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Angiographic Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Angiographic Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Angiographic Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Angiographic Catheters by Application - Coronary, Neurology, Endovascular and Oncology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 109: Asia-Pacific 16-Year Perspective for Angiographic Catheters by Application - Percentage Breakdown of Value Sales for Coronary, Neurology, Endovascular and Oncology for the Years 2014, 2024 & 2030
  • Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 111: Asia-Pacific Historic Review for Angiographic Catheters by End-Use - Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 112: Asia-Pacific 16-Year Perspective for Angiographic Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Angiographic Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

Some of the 42 companies featured in this Global Angiographic Catheters market report include:
  • Alvimedica Medical Devices Inc.
  • Angiodynamics Inc
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C.R. Bard, Inc. (A Part of Becton, Dickinson and Company)
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Medtronic PLC.
  • Merit Medical System Inc
  • Terumo Medical Corporation

Table Information